AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Bure Equity M&A Activity 2011

Jul 4, 2011

2899_rns_2011-07-04_afa120cb-c907-45f0-ab41-734b21f9b4ac.pdf

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

PRESSMEDDELANDE Stockholm, den 4 juli 2011

PORTFÖLJBOLAGET CMA MICRODIALYSIS OMSTRUKTURERAR VERKSAMHETEN

Bure Equitys portföljbolag CMA Microdialysis avyttrar sin prekliniska verksamhet, säljer dotterbolaget Dilab och byter namn på den kvarvarande verksamheten till Dipylon Medical AB.

För mer information se bifogade pressmeddelanden samt Dipylon Medicals hemsida:

www.dipylonmedical.com

Stockholm den 4 juli 2011

Bure Equity AB (publ)

Kontaktperson på Bure:

Patrik Tigerschiöld, VD Tel: 08-614 00 20

AI assistant

Bure Equity — M&A Activity 2011

2899_rns_2011-07-04_afa120cb-c907-45f0-ab41-734b21f9b4ac.pdf

PORTFÖLJBOLAGET CMA MICRODIALYSIS OMSTRUKTURERAR VERKSAMHETEN

Kontaktperson på Bure:

More from Bure Equity

Bure Equity M&A Activity 2011